1. Honda, Hiroshi, Pazin, Michael J, D'Souza, Theresa, Ji, Hongxiu, Morin, Patrice J. 2007. Regulation of the CLDN3 gene in ovarian cancer cells. In Cancer biology & therapy, 6, 1733-42. doi:. https://pubmed.ncbi.nlm.nih.gov/17986852/
2. Roth, Mark J, Abnet, Christian C, Hu, Nan, Taylor, Philip R, Woodson, Karen. . p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. In Oncology reports, 15, 1591-7. doi:. https://pubmed.ncbi.nlm.nih.gov/16685400/
3. Liu, Wenzheng, Kuai, Yiyang, Wang, Da, Wang, Bing, Chen, Yongjun. 2024. PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2407323. doi:10.1002/advs.202407323. https://pubmed.ncbi.nlm.nih.gov/39477806/
4. Marincola Smith, Paula, Choksi, Yash A, Markham, Nicholas O, Means, Anna L, Beauchamp, R Daniel. 2021. Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice. In American journal of physiology. Gastrointestinal and liver physiology, 320, G936-G957. doi:10.1152/ajpgi.00053.2021. https://pubmed.ncbi.nlm.nih.gov/33759564/
5. Jiang, Lei, Yang, Yi-Dong, Fu, Li, Sung, Joseph J Y, Yu, Jun. . CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma. In Oncotarget, 5, 7663-76. doi:. https://pubmed.ncbi.nlm.nih.gov/25277196/
6. Nomiri, Samira, Karami, Hassan, Baradaran, Behzad, Safarpour, Hossein, Silvestris, Nicola. 2021. Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146, 112537. doi:10.1016/j.biopha.2021.112537. https://pubmed.ncbi.nlm.nih.gov/34922114/
7. Uthayanan, Leshanth, El-Bahrawy, Mona. 2022. Potential roles of claudin-3 and claudin-4 in ovarian cancer management. In Journal of the Egyptian National Cancer Institute, 34, 24. doi:10.1186/s43046-022-00125-4. https://pubmed.ncbi.nlm.nih.gov/35665865/
8. Jiang, Fengru, Li, Sumei, Wang, Xiaoyun, Deng, Yingzhao, Peng, Shuying. . DPP10-AS1-Mediated Downregulation of MicroRNA-324-3p Is Conducive to the Malignancy of Pancreatic Cancer by Enhancing CLDN3 Expression. In Pancreas, 51, 1201-1210. doi:10.1097/MPA.0000000000002164. https://pubmed.ncbi.nlm.nih.gov/37078946/
9. Huang, Yu-Hung, Bao, Yunhua, Peng, Weidan, Anderson, Daniel G, Sawicki, Janet A. 2009. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. In Proceedings of the National Academy of Sciences of the United States of America, 106, 3426-30. doi:10.1073/pnas.0813348106. https://pubmed.ncbi.nlm.nih.gov/19208807/
10. Arrojo, Maria Luiza, Oliveira, Katia Klug, Bettim, Bárbara Beltrame, Lourenço, Silvia Vanessa, Coutinho-Camillo, Cláudia Malheiros. 2022. Tight junction gene expression in salivary gland tumors. In Pathology, research and practice, 238, 154113. doi:10.1016/j.prp.2022.154113. https://pubmed.ncbi.nlm.nih.gov/36099718/
智鼠故事 
